ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002

Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available.

January 23, 2004

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement

March 18, 1994

In Brief: CCIRC Recommends Central Oncology Group For Phasing Out; Rogers Backs Pay Raise

March 5, 1976